These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34121634)

  • 1. Sociodemographic characteristics associated with hepatitis C among patients admitted for medically managed opioid withdrawal in east Tennessee.
    Alexander R; Agboola O; Costales V
    J Addict Dis; 2022; 40(1):92-95. PubMed ID: 34121634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Prescription Opioids as a High-Risk Indicator for Hepatitis C Infection: Another Step Toward HCV Elimination.
    Hack B; Timalsina U; Tefera E; Wilkerson B; Paku E; Fernandez S; Fishbein D
    J Prim Care Community Health; 2021; 12():21501327211034379. PubMed ID: 34467805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial.
    Hochstatter KR; Gustafson DH; Landucci G; Pe-Romashko K; Cody O; Maus A; Shah DV; Westergaard RP
    JMIR Mhealth Uhealth; 2021 Feb; 9(2):e23080. PubMed ID: 33616545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use.
    Spaderna M; Kattakuzhy S; Kang SJ; George N; Bijole P; Ebah E; Eyasu R; Ogbumbadiugha O; Silk R; Gannon C; Davis A; Cover A; Gayle B; Narayanan S; Pao M; Kottilil S; Rosenthal E
    Int J Drug Policy; 2023 Jan; 111():103906. PubMed ID: 36384062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Tennessee's county-level vulnerability to hepatitis C virus and HIV outbreaks using socioeconomic, healthcare, and substance use indicators.
    Vakili J; Sizemore L; Rebeiro PF; Tyndall B; Talley P; Whaley K; Brantley M
    PLoS One; 2022; 17(8):e0270891. PubMed ID: 35925969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.
    Zibbell JE; Iqbal K; Patel RC; Suryaprasad A; Sanders KJ; Moore-Moravian L; Serrecchia J; Blankenship S; Ward JW; Holtzman D;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):453-8. PubMed ID: 25950251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
    Choi S; Healy S; Shapoval L; Forthal S; Neighbors CJ
    Subst Use Misuse; 2021; 56(2):258-263. PubMed ID: 33345680
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
    Tsui JI; Evans JL; Lum PJ; Hahn JA; Page K
    JAMA Intern Med; 2014 Dec; 174(12):1974-81. PubMed ID: 25347412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
    Rosenthal ES; Silk R; Mathur P; Gross C; Eyasu R; Nussdorf L; Hill K; Brokus C; D'Amore A; Sidique N; Bijole P; Jones M; Kier R; McCullough D; Sternberg D; Stafford K; Sun J; Masur H; Kottilil S; Kattakuzhy S
    Clin Infect Dis; 2020 Oct; 71(7):1715-1722. PubMed ID: 32009165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder.
    Springer SA
    Clin Infect Dis; 2020 Jun; 70(12):2703-2705. PubMed ID: 31346595
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico.
    Wagner K; Zhong Y; Teshale E; White K; Winstanley EL; Hettema J; Thornton K; Bisztray B; Fiuty P; Page K
    Drug Alcohol Depend; 2021 Mar; 220():108527. PubMed ID: 33465605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
    Pergolizzi JV; Raffa RB; Rosenblatt MH
    J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Opioid Use Disorder After Breast Reconstruction: Effects of Nicotine Exposure.
    Groff D; Freedman Z; Gilles A; Bone C; Johnson TS
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S241-S244. PubMed ID: 38556681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.
    Seval N; Wurcel A; Gunderson CG; Grimshaw A; Springer SA
    Infect Dis Clin North Am; 2020 Sep; 34(3):559-584. PubMed ID: 32782102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.
    Assoumou SA; Wang J; Nolen S; Eftekhari Yazdi G; Mayer KH; Puro J; Salomon JA; Linas BP
    J Gen Intern Med; 2020 May; 35(5):1477-1483. PubMed ID: 32133577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis C virus among fatal drug overdoses in Tennessee: an analysis using 2019-2020 Tennessee State Unintentional Drug Overdose Reporting System Data.
    Korona-Bailey J; Riley Saint S; Sizemore L; Wingate H; Shoup P; Hawes A; Mukhopadhyay S
    Ann Epidemiol; 2023 Apr; 80():1-8. PubMed ID: 36758846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of co-occurring substance use in individuals with opioid use disorder.
    Mahoney JJ; Winstanley EL; Lander LR; Berry JH; Marshalek PJ; Haut MW; Marton JL; Kimble WD; Armistead M; Wen S; Cai Y; Hodder SL
    Addict Behav; 2021 Mar; 114():106752. PubMed ID: 33348147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.
    Zibbell JE; Asher AK; Patel RC; Kupronis B; Iqbal K; Ward JW; Holtzman D
    Am J Public Health; 2018 Feb; 108(2):175-181. PubMed ID: 29267061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.